Global Med Technologies Inc. reported unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2009. For the quarter, the company reported net loss of $219,000 or $0.01 per basic and diluted share on revenues of $8,113,000 compared to net loss of $703,000 or $0.02 per basic and diluted share on revenues of $6,991,000 for the same period of last year. Loss from operations was $97,000 compared to $664,000 for the same period of last year. Pre-tax loss was $263,000 compared to $834,000 for the same period of last year. EBITDA was $278,000 compared to $332,000 for the same period of last year. For the year, the company reported net income of $1,478,000 or $0.03 per basic and diluted share on revenues of $31,788,000 compared to net loss of $419,000 or $0.01 per basic and diluted share on revenues of $23,369,000 for the same period of last year. Income from operations was $2,705,000 compared to $176,000 for the same period of last year. Pre-tax income was $1,997,000 compared to pre-tax loss of $120,000 for the same period of last year. EBITDA was $4,123,000 compared to $970,000 for the same period of last year.

Global Med Technologies Inc. reported unaudited operating results for the third quarter and nine months ended September 30, 2009. The company reported record net income of $1.10 million or earnings of $0.02 per diluted common share, for the three months ended September 30, 2009 compared to a net loss of $228,000, or a loss of $0.01 per diluted common share for the comparable period in 2008. This represents a $1.33 million increase in net income for the third quarter of 2009 when compared with the comparable period in 2008. In the third quarter of 2009, operating income improved to $1.12 million from a $118,000 loss during the comparable 2008 period. Revenues were $7.3 million against $6.9 million a year ago. EBITDA was $1.5 million against $230,000 a year ago. For the first nine months of 2009, the company's revenues increased to $23.68 million or a 45% increase over the $16.38 million in revenues recognized during the comparable period in 2008. The company's third quarter revenues increased to $7.26 million representing a 5% increase from the $6.94 million in the comparable period in 2008. While the company's acquisitions of Inlog and eDonor in 2008 were the primary drivers of revenue growth for the three and nine months ended September 30, 2009, the company's organic business also experienced revenue growth during these periods when compared with the comparable periods during 2008. For the nine months ended September 30, 2009, income from operations improved to $2.80 million from $840,000 for the comparable period during 2008. The company's net income for the first nine months of 2009 was $1.70 million, or $0.04 per diluted common share outstanding, versus $284,000, or $0.01 per diluted common share, for the comparable period during 2008. The company's cash flow from operations for the first nine months of 2009 was $3.87 million, a more than 248% increase over the $1.11 million recorded for the first nine months of 2008. EBITDA was $3.85 million against $1.3 million a year ago.

Global Med Technologies Inc., Q3 2009 Earnings Call, Nov 11 2009

GLOBAL MED TECHNOLOGIES INC Files SEC form 10-K, Annual Report

Global Med Technologies(R) Reports Q4 and Year End Results

GLOBAL MED TECHNOLOGIES INC Files SEC form 8-K, Other Events, Financial Statements and Exhibits

Global Med Technologies(R) Reports Q4 and Year End Results

Haemonetics shares dip on 3Q results; big purchase

Liberty Analytics Co. Initiates Independent Research Coverage on Global Med Technologies, Inc.

GLOBAL MED TECHNOLOGIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement

Haemonetics Announces Definitive Agreement to Acquire Global Med Technologies, Inc.

Levi & Korsinsky, LLP Investigates Possible Breach of Fiduciary Duty by the Board of Global Medical Technologies Inc. - GLOB

Haemonetics shares dip on 3Q results; big purchase

Finkelstein Thompson LLP Announces Investigation of Global Med Technologies, Inc.

Bull & Lifshitz, LLP Announces Investigation of Global Med Technologies, Inc.

Liberty Analytics Co. Initiates Independent Research Coverage on Global Med Technologies, Inc.

Law Offices of Howard G. Smith Announces Investigation on Behalf of Shareholders of Global Med Technologies, Inc.

Law Offices of Howard G. Smith Announces Investigation on Behalf of Shareholders of Global Med Technologies, Inc.

Finkelstein Thompson LLP Announces Investigation of Global Med Technologies, Inc.

Bull & Lifshitz, LLP Announces Investigation of Global Med Technologies, Inc.

Liberty Analytics Co. Initiates Independent Research Coverage on Global Med Technologies, Inc.

GLOBAL MED TECHNOLOGIES INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and

UPDATE - Haemonetics results misses view; to buy Global Med